Cargando…
Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents
Modulation of the DNA repair pathway is an emerging target for the development of anticancer drugs. DNA interstrand cross-links (ICLs), one of the most severe forms of DNA damage caused by anticancer drugs such as cisplatin and mitomycin C (MMC), activates the Fanconi anemia (FA)/BRCA DNA repair pat...
Autores principales: | Wha Jun, Dong, Hwang, Mihwa, Kim, Hyun Jung, Hwang, Soo Kyung, Kim, Sunshin, Lee, Chang-Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790830/ https://www.ncbi.nlm.nih.gov/pubmed/24124520 http://dx.doi.org/10.1371/journal.pone.0075905 |
Ejemplares similares
-
AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks
por: Chun, Min Jeong, et al.
Publicado: (2016) -
Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage
por: Chun, Min Jeong, et al.
Publicado: (2016) -
Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair
por: Li, Niu, et al.
Publicado: (2020) -
Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway
por: Lopez-Martinez, David, et al.
Publicado: (2016) -
Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism
por: Chun, Min Jeong, et al.
Publicado: (2017)